Romania Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
November 19, 2014
111 Pages - SKU: BMI5388644
Countries covered: Romania

Romania Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push theburden further onto innovative drugmakers. With an improving macroeconomic outlook, increasedgovernment spending is on the horizon, and that will undoubtedly benefit the pharmaceutical sector.

However, stalling Eurozone growth could worsen dynamics within Romania.

Headline Expenditure Projections

Pharmaceuticals: RON13.96bn (USD4.17bn) in 2013 to RON14.65bn (USD4.38bn) in 2014; +5.0% inlocal currency terms and 5.0% in US dollar terms.

Healthcare: RON30.05bn (USD8.97bn) in 2013 to RON31.30bn (USD9.35bn) in 2014; +4.1% in localcurrency terms and 4.2% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Taiwan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Taiwan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical andhealthcare investment, ...
Switzerland Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Swiss government will need to develop policies to maintain the country's long-termattractiveness as a site for ...
Sudan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sudan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The already depreciating Sudanese pound will come under further strain should oil pricescontinue their decline as oil ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly asthe government sees the ...
See all reports like this >>

More Romania Prescription Drugs reports

Romania Pharmaceutical Report - Q2, 2014 by Intellinews
Romania Pharmaceutical Report - Q2, 2014This report covers the market developments in Q2/2014 and the data available as of August 2014. Sales of pharmaceuticals ...
Pharmaceuticals: Romania Pharmaceutical Report - Q1, 2014 by Intellinews
Romania Pharmaceutical Report - Q1, 2014This report covers the market developments in Q1/2014 and the data available as of May 2014. The pharmaceutical sales dropped ...
Antibiotics Market in Romania to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Romania. The study provides essential market ...
The Pharmaceutical Market: Romania by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!